Seer reported revenue of $3.6 million for Q2 2022, an increase compared to $1.3 million in Q2 2021. The company's gross profit was $1.6 million with a gross margin of 44%. Net loss for the quarter was $22.8 million. Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
Revenue for Q2 2022 reached $3.6 million.
Launched Proteograph Analysis Suite 2.0 for proteogenomic analysis.
Featured in 28 posters across nine scientific conferences.
Progressed with Centers of Excellence and the Proteogenomics Consortium.
Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance